FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,950 | -12.9% | 46,332 | +2.4% | 0.00% | – |
| Q2 2023 | $399,483 | +43.2% | 45,242 | +0.7% | 0.00% | – |
| Q1 2021 | $279,000 | -18.4% | 44,912 | -2.1% | 0.00% | – |
| Q4 2020 | $342,000 | +16.3% | 45,866 | -5.7% | 0.00% | – |
| Q3 2020 | $294,000 | -27.2% | 48,625 | +0.4% | 0.00% | – |
| Q2 2020 | $404,000 | +264.0% | 48,439 | +112.4% | 0.00% | – |
| Q1 2019 | $111,000 | -23.4% | 22,804 | 0.0% | 0.00% | – |
| Q4 2018 | $145,000 | -22.5% | 22,804 | +0.1% | 0.00% | – |
| Q3 2018 | $187,000 | -21.1% | 22,789 | 0.0% | 0.00% | – |
| Q2 2018 | $237,000 | – | 22,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |